ELV Elevance Health, Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 6, 2026 10-K/10-Q Lip 15, 2026ELV Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
ELV Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 1 czerwca 2005 | 2-for-1 | Naprzód |
O Elevance Health, Inc. Common Stock Przegląd firmy z Wikipedii
Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.
Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.
History
Anthem
In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.
In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.
In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.
In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.
In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.
In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.
In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.
In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.
Blue Cross of California
Blue Cross of California was the predecessor of WellPoint Health Network Inc.
In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).
In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.
In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second-largest publicly held managed health company in the U.S. with 4 million policyholders.
In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.
In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.
In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.
In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.
In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.
In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.
In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.
In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.
On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.
Anthem, Inc.
In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.
In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.
On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.
On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".
Elevance Health
On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.
As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.
Subsidiaries
Elevance Health includes the following subsidiaries:
Amerigroup
District of Columbia (Medicaid)
Georgia (Medicaid)
New Mexico (Medicare Advantage)
Anthem Blue Cross
California
Blue Cross of California Partnership Plan (Medicaid)
New York (upstate)
Anthem Blue Cross Blue Shield
Colorado
Connecticut
Georgia
Indiana (includes Medicaid)
Kentucky
Anthem Blue Cross and Blue Shield Medicaid
Maine
Missouri (excluding 30 counties in the Kansas City area)
Nevada
Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)
New Hampshire
New York (downstate)
HealthPlus (Medicaid)
Ohio
Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)
HealthKeepers (Medicaid)
Wisconsin
Carelon Behavioral Health
Carelon Behavioral Health of California
Carelon Behavioral Health of Kansas
Carelon Health of Pennsylvania
Carelon Global Solutions (Business Process Outsourcing/Shared Services)
Freedom Health
Florida
Golden West Dental & Vision
California
HealthSun
Florida
MMM
Puerto Rico
Optimum Healthcare
Florida
Simply Healthcare
Florida
UniCare
West Virginia
WellPoint
Arizona (Medicare Advantage)
Iowa (Medicaid and Medicare Advantage)
Maryland (Medicaid)
Massachusetts (government employees)
New Jersey (Medicaid and Medicare Advantage)
Tennessee (Medicaid and Medicare Advantage)
Texas (Medicaid and Medicare Advantage)
Washington (Medicaid and Medicare Advantage)
Joint ventures
Elevance Health operates joint ventures including:
Anthem | MaineHealth (with MaineHealth)
Maine
Blue Medicare Advantage (with Independence Blue Cross)
Pennsylvania
Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)
Colorado
Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)
Kansas
Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)
Louisiana
Summit Community Care
Arkansas
Centers Plan for Healthy Living
New York, Florida
Quality of care
In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).
Controversies
Charitable donations
In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.
2007 DMHC investigation
In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.
In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.
2010 Reuters exposé
In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.
In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.
Opposition to healthcare reform
In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.
Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.
Premium increases in Maine
In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.
Rate increases in California
In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.
To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.
In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.
Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".
WellPoint cost reclassification
On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.
2009–2010 data breach
In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.
Denial of benefits for cancer treatment
In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.
2015 data breach
On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.
"Avoidable ER program"
Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.
Neglecting complaints
In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.
2019 lawsuit for coercive direct payments
In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.
Diagnostics fraud
In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.
Medicare Advantage star rating
In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.
Finances
For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.
Recognition
The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | ELV | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 17.7średnia z 5 lat ≈17.3 | ≈17.3 | 36.3 | Niedowartościowany | |
| P/S (TTM) | 0.4średnia z 5 lat ≈0.6 | ≈0.6 | 0.7 | Niedowartościowany | |
| P/B (MRQ) | 1.9średnia z 5 lat ≈2.6 | ≈2.6 | 3.9 | Niedowartościowany | |
| EV / EBITDA | 12.7średnia z 5 lat ≈12.8 | ≈12.8 | 16.1 | Niedowartościowany | |
| Cena / FCF (TTM) | 13.8średnia z 5 lat ≈18.3 | ≈18.3 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 11.6średnia z 5 lat ≈14.8 | ≈14.8 | 15.6 | Zawyżona wycena | |
| EV / Revenue (EV / Przychody) | 0.6średnia z 5 lat ≈0.7 | ≈0.7 | · | · | |
| EV / FCF | 34.9średnia z 5 lat ≈22.2 | ≈22.2 | · | · | |
| Cena / Wartość księgowa materialna (MRQ) | 2.6średnia z 5 lat ≈61.0 | ≈61.0 | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈2.5 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | ELV | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 2.7%średnia z 5 lat ≈4.8% | ≈4.8% | 3.5% | Zgodnie z | |
| Marża EBITDA (TTM) | 3.5%średnia z 5 lat ≈5.7% | ≈5.7% | 3.7% | Słaby | |
| Marża przed opodatkowaniem (TTM) | 2.9%średnia z 5 lat ≈4.6% | ≈4.6% | 2.8% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 2.5%średnia z 5 lat ≈3.6% | ≈3.6% | 2.9% | Zgodnie z | |
| ROA (TTM) | 4.0%średnia z 5 lat ≈5.7% | ≈5.7% | 3.0% | Najwyższa półka | |
| ROE (TTM) | 11.2%średnia z 5 lat ≈15.5% | ≈15.5% | 10.1% | Najwyższa półka | |
| ROIC | 8.0%średnia z 5 lat ≈9.4% | ≈9.4% | 8.0% | Zgodnie z |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | ELV | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Dług / Kapitał Własny (MRQ) | 0.7średnia z 5 lat ≈0.7 | ≈0.7 | 0.7 | Zgodnie z | |
| Wskaźnik bieżący (MRQ) | 1.5średnia z 5 lat ≈1.5 | ≈1.5 | 1.7 | Niska płynność | |
| Quick Ratio (Wskaźnik Szybkości) | 0.2średnia z 5 lat ≈0.2 | ≈0.2 | 1.3 | Niska płynność | |
| Dług długoterminowy / Kapitał własny (MRQ) | 0.7średnia z 5 lat ≈0.6 | ≈0.6 | 0.7 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | ELV | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 12.5%średnia z 5 lat ≈10.4% | ≈10.4% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 8.3%średnia z 5 lat ≈9.6% | ≈9.6% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 10.3% | · | · | · | |
| EPS YoY | -1.8%średnia z 5 lat ≈8.0% | ≈8.0% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -5.3%średnia z 5 lat ≈5.3% | ≈5.3% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 1.3%średnia z 5 lat ≈4.7% | ≈4.7% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 7.0% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | -1.3%średnia z 5 lat ≈2.4% | ≈2.4% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | 4.4% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | ELV | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 1.7średnia z 5 lat ≈1.6 | ≈1.6 | 2.4 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$2.1M | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
| Data ex-dywidendy | Kwota | Waluta | Stopa zwrotu |
|---|---|---|---|
| Wrz 10, 2026 | $1,72 | USD | ≈1.6% |
| Cze 10, 2026 | $1,72 | USD | ≈1.7% |
| Mar 10, 2026 | $1,72 | USD | ≈2.4% |
| Gru 5, 2025 | $1,71 | USD | ≈2.1% |
| Wrz 10, 2025 | $1,71 | USD | ≈2.2% |
| Cze 10, 2025 | $1,71 | USD | ≈1.7% |
| Mar 10, 2025 | $1,71 | USD | ≈1.6% |
| Gru 5, 2024 | $1,63 | USD | ≈1.7% |
| Wrz 10, 2024 | $1,63 | USD | ≈1.2% |
| Cze 10, 2024 | $1,63 | USD | ≈1.2% |
| Mar 7, 2024 | $1,63 | USD | ≈1.2% |
| Gru 5, 2023 | $1,48 | USD | ≈1.2% |
| Wrz 7, 2023 | $1,48 | USD | ≈1.3% |
| Cze 8, 2023 | $1,48 | USD | ≈1.2% |
| Mar 9, 2023 | $1,48 | USD | ≈1.2% |
| Gru 2, 2022 | $1,28 | USD | ≈0.98% |
| Wrz 8, 2022 | $1,28 | USD | ≈1.0% |
| Cze 9, 2022 | $1,28 | USD | ≈0.99% |
| Mar 9, 2022 | $1,28 | USD | ≈1.0% |
| Gru 2, 2021 | $1,13 | USD | ≈1.1% |
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Lip 15, 2026 | $7.45 | $6.27 | 18.9% |
| 31 marca 2026 | $12.58 | $10.93 | 15.1% | |
| 31 grudnia 2025 | $3.33 | $3.13 | 6.5% | |
| 30 września 2025 | $6.03 | $4.98 | 21.0% | |
| 30 czerwca 2025 | $8.84 | $9.04 | -2.3% | |
| 31 marca 2025 | $11.97 | $11.50 | 4.1% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Cost of Revenue | $21.18B | $19.75B | $17.29B | $13.04B | $10.89B | $8.95B | $1.99B | $0 | $0 | · | · | · | |
| SG&A Expense | $20.98B | $20.02B | $20.09B | $17.70B | $15.92B | $17.45B | $13.36B | $14.02B | $12.65B | $12.56B | $12.53B | $11.75B | |
| Operating Income | $7.20B | $7.86B | $8.50B | $8.28B | $7.56B | $6.36B | $6.00B | $5.43B | $4.17B | $4.80B | $4.75B | $4.42B | |
| Interest Expense | · | · | $1.03B | $851M | $798M | $784M | $746M | $753M | $739M | $723M | $653M | $601M | |
| Pretax Income | $6.71B | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B | $5.99B | $5.07B | $3.96B | $4.55B | $4.63B | $4.37B | |
| Income Tax | $1.05B | $1.93B | $1.72B | $1.71B | $1.85B | $1.67B | $1.18B | $1.32B | $121M | $2.08B | $2.07B | $1.81B | |
| Net Income | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| EPS (Basic) | $25.28 | $25.81 | $25.38 | $24.56 | $25.26 | $18.23 | $18.81 | $14.53 | $14.70 | $9.39 | $9.73 | $9.31 | |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 | |
| Shares (Basic) | 224,000,000 | 231,700,000 | 235,900,000 | 240,000,000 | 243,800,000 | 250,800,000 | 255,500,000 | 258,100,000 | 261,500,000 | 262,900,000 | 263,000,000 | 275,900,000 | |
| Shares (Diluted) | 224,600,000 | 232,900,000 | 237,400,000 | 242,800,000 | 246,800,000 | 254,300,000 | 260,300,000 | 264,200,000 | 267,800,000 | 268,100,000 | 272,900,000 | 285,900,000 | |
| EBITDA | $8.74B | $9.26B | $10.24B | $10.13B | $8.79B | $7.51B | $6.00B | $5.43B | $4.18B | $4.80B | $4.75B | $4.42B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9.49B | $8.29B | $6.53B | $7.39B | $4.88B | $5.74B | $4.94B | $3.93B | $3.61B | $4.08B | $2.11B | $2.15B | |
| Other Current Assets | $5.34B | $4.70B | $5.79B | $5.28B | $4.65B | $4.06B | $3.02B | $2.10B | $2.25B | $1.78B | $1.56B | $1.47B | |
| Current Assets | $63.00B | $58.94B | $60.03B | $55.62B | $51.12B | $45.75B | $39.03B | $34.32B | $36.26B | $34.31B | $30.86B | $31.95B | |
| PP&E (Net) | $4.68B | $4.65B | $4.36B | $4.32B | $3.92B | $3.48B | $3.13B | $2.73B | $2.17B | $1.98B | $2.02B | $1.94B | |
| PP&E (Gross) | $8.73B | $8.33B | $7.90B | $7.12B | $8.26B | $7.33B | $6.48B | $5.55B | $4.37B | $4.14B | $4.06B | $3.76B | |
| Accum. Depreciation | $4.06B | $3.68B | $3.54B | $2.80B | $4.34B | $3.84B | $3.35B | $2.81B | $2.20B | $2.16B | $2.04B | $1.82B | |
| Goodwill | $28.34B | $28.28B | $25.32B | $24.38B | $24.23B | $21.69B | $20.50B | $20.50B | $19.23B | $17.56B | $17.56B | $17.08B | |
| Intangibles | $11.20B | $12.09B | $10.27B | $10.31B | $10.62B | $9.40B | $8.67B | $9.01B | $8.37B | $7.96B | $8.16B | $7.96B | |
| Other Non-current Assets | $2.31B | $2.14B | $1.97B | $1.69B | $1.72B | $1.44B | $1.35B | $758M | $565M | $468M | $485M | $512M | |
| Total Assets | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Accounts Payable | $7.32B | $6.93B | $6.91B | $5.61B | $4.97B | $5.49B | $4.20B | $4.96B | $5.02B | $4.01B | $3.32B | $3.65B | |
| Short-term Debt | $150M | $365M | $225M | $265M | $275M | $0 | $700M | $1.15B | $1.27B | $440M | $540M | $400M | |
| Current Liabilities | $41.03B | $40.58B | $41.79B | $39.70B | $34.88B | $29.45B | $23.53B | $21.96B | $23.36B | $21.29B | $19.09B | $18.75B | |
| Capital Leases | $529M | $658M | $685M | $751M | $864M | · | · | · | · | · | · | · | |
| Deferred Tax | $2.11B | $2.15B | $1.97B | $2.02B | $2.81B | $2.02B | $2.23B | $1.96B | $1.73B | $2.78B | $2.63B | $2.95B | |
| Other Non-current Liabilities | $3.53B | $3.33B | $1.74B | $1.56B | $1.68B | $1.81B | $1.42B | $1.18B | $925M | $884M | $994M | $1.04B | |
| Total Liabilities | $77.47B | $75.46B | $69.52B | $66.42B | $61.29B | $53.42B | $45.73B | $43.03B | $44.04B | $39.98B | $38.67B | $37.42B | |
| Long-term Debt | $31.90B | $30.87B | $24.89B | $23.85B | $22.76B | $20.04B | $19.39B | $18.07B | $18.66B | $15.29B | $15.32B | $14.64B | |
| Total Debt | $32.05B | $31.23B | $25.12B | $24.11B | $23.03B | $20.04B | $20.09B | $19.21B | $19.93B | $15.73B | $15.86B | $15.15B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Paid-in Capital | $8.94B | $8.91B | $8.87B | $9.08B | $9.15B | $9.24B | $9.45B | $9.54B | $8.55B | $8.81B | $8.56B | $10.06B | |
| Retained Earnings | $35.39B | $33.55B | $31.75B | $29.65B | $27.14B | $23.80B | $22.57B | $19.99B | $18.05B | $16.56B | $14.78B | $14.01B | |
| AOCI | $-451M | $-1.15B | $-1.31B | $-2.49B | $-197M | $150M | $-296M | $-986M | $-101M | $-268M | $-293M | $172M | |
| Stockholders' Equity | $43.88B | $41.31B | $39.31B | $36.24B | $36.09B | $33.20B | $31.73B | $28.54B | $26.50B | $25.10B | $23.05B | $24.25B | |
| Liabilities + Equity | $121.49B | $116.89B | $108.93B | $102.75B | $97.46B | $86.61B | $77.45B | $71.57B | $70.54B | $65.08B | $61.72B | $61.68B | |
| Shares Outstanding | 220,723,898 | 227,479,695 | 233,071,088 | 237,958,067 | 241,770,746 | 245,401,430 | 252,922,161 | 257,395,577 | 256,084,913 | 263,747,395 | 261,238,188 | 268,109,932 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.55B | $1.39B | $1.75B | $1.68B | $1.30B | $1.15B | $1.13B | $1.13B | · | · | · | · | |
| Stock-based Comp | $276M | $191M | $289M | $264M | $255M | $283M | $294M | $226M | $170M | $165M | $148M | $169M | |
| Deferred Tax | $-279M | $-374M | $-602M | $-115M | $342M | $-540M | $81M | $91M | $-1.27B | $127M | $-66M | $31M | |
| Amort. of Intangibles | $628M | $580M | $885M | $767M | $441M | $361M | $338M | $358M | $169M | $192M | $230M | $221M | |
| Other Non-cash | $-2.92B | $-1.38B | $642M | $511M | $377M | $5.22B | · | · | · | · | · | · | |
| Operating Cash Flow | $4.29B | $5.81B | $8.06B | $8.40B | $8.36B | $10.69B | $6.06B | $3.83B | $4.18B | $3.27B | $4.21B | $3.37B | |
| CapEx | $1.12B | $1.26B | $1.30B | $1.15B | $1.09B | $1.02B | $1.08B | $1.21B | $791M | $584M | $638M | $715M | |
| Investing Cash Flow | $-1.34B | $-5.17B | $-5.57B | $-4.56B | $-9.64B | $-7.32B | $-2.79B | $-1.26B | $-5.08B | $-514M | $-1.15B | $-975M | |
| Debt Issued | $2.99B | $7.71B | $2.57B | $3.07B | $3.46B | $2.48B | $2.47B | $835M | $5.46B | $0 | $1.23B | $2.70B | |
| Net Debt Issued | $844M | $6.06B | $665M | $1.17B | $2.39B | $552M | $1.35B | $-849M | $2.64B | $0 | $-1.47B | $970M | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $1.25B | $0 | $0 | · | · | |
| Stock Repurchased | $2.60B | $2.90B | $2.68B | $2.32B | $1.90B | $2.70B | $1.70B | $1.69B | $2.00B | $0 | $1.52B | $3.00B | |
| Net Stock Activity | $-2.60B | $-2.90B | $-2.68B | $-2.32B | $-1.90B | $-2.70B | $-1.70B | $-435M | $-2.00B | $0 | $-1.52B | $-3.00B | |
| Dividends Paid | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M | |
| Financing Cash Flow | $-1.74B | $1.19B | $-3.35B | $-1.32B | $423M | $-2.57B | $-2.27B | $-2.24B | $427M | $-799M | $-3.09B | $-1.82B | |
| Net Change in Cash | $1.20B | $1.83B | $-861M | $2.51B | $-861M | $804M | $1.00B | $325M | $-466M | $1.96B | $-38M | $565M | |
| Free Cash Flow | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B | $9.67B | $4.98B | $2.62B | $3.39B | $2.62B | $3.48B | $2.65B | |
| Levered FCF | · | · | $5.97B | $6.59B | $6.66B | $9.09B | $4.38B | $2.06B | $2.67B | $2.23B | $3.12B | $2.30B |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% | 5.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| Net Margin | 2.8% | 3.4% | 3.5% | 3.9% | 4.4% | 3.8% | 4.6% | 4.1% | 4.3% | 2.9% | 3.2% | 3.5% | |
| Pretax Margin | 3.4% | 4.5% | 4.5% | 5.0% | 5.7% | 5.1% | 5.7% | 5.5% | 4.4% | 5.4% | 5.9% | 5.9% | |
| EBITDA Margin | 4.4% | 5.2% | 6.0% | 6.5% | 6.3% | 6.2% | 5.8% | 5.9% | 4.6% | 5.7% | 6.0% | 6.0% | |
| ROA | 4.8% | 5.3% | 5.7% | 6.0% | 6.6% | 5.6% | 6.5% | 5.3% | 5.7% | 3.9% | 4.2% | 4.2% | |
| ROE | 13.3% | 14.8% | 15.8% | 16.7% | 17.0% | 13.6% | 15.2% | 13.0% | 14.6% | 9.9% | 11.1% | 10.6% | |
| ROIC | 8.0% | 8.2% | 10.2% | 10.8% | 9.8% | 8.8% | 9.3% | 8.4% | 8.7% | 6.4% | 6.8% | 6.6% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 | 1.6 | 1.7 | 1.6 | 1.6 | 1.6 | 1.6 | 1.7 | |
| Quick Ratio | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Debt / Equity | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.6 | 0.7 | 0.6 | |
| Interest Coverage | · | · | 8.3 | 9.9 | 9.4 | 8.1 | 8.0 | 7.2 | 5.7 | 6.6 | 7.3 | 7.4 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.7 | 1.6 | 1.6 | 1.6 | 1.5 | 1.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $198.81 | $181.62 | $168.64 | $152.58 | $149.15 | $135.28 | $125.45 | $110.88 | $103.49 | $95.17 | $88.21 | $90.45 | |
| Revenue / Share | $886.58 | $760.03 | $721.74 | $644.95 | $561.75 | $479.23 | $400.36 | $348.62 | $336.22 | $316.53 | $290.06 | $258.39 | |
| Cash Flow / Share | $19.10 | $24.94 | $33.96 | $34.59 | $33.89 | $42.03 | $23.28 | $14.49 | $15.63 | $11.95 | $15.08 | $11.78 | |
| Cash / Share | $43.00 | $36.43 | $28.00 | $31.04 | $20.18 | $23.39 | $19.52 | $15.28 | $14.09 | $15.45 | $8.09 | $8.03 | |
| Dividend / Share | · | · | $5.92 | $5.12 | $4.52 | $3.80 | $3.20 | $3.00 | $2.70 | $2.60 | $2.50 | $1.75 | |
| EPS (TTM) | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 | $17.98 | $18.47 | $14.19 | $14.35 | $9.21 | $9.38 | $8.99 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 12.5% | 3.3% | 9.4% | 13.0% | 13.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 8.3% | 8.5% | 12.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -1.8% | 1.8% | 3.9% | -2.7% | 38.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 1.3% | 0.97% | 11.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 7.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -5.3% | -0.12% | 1.6% | -4.3% | 34.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -1.3% | -0.97% | 9.4% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 4.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 9.9% | · | · | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B | $121.87B | $104.21B | $92.11B | $90.04B | $84.86B | $79.16B | $73.87B | |
| Net Income TTM | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B | $4.81B | $3.75B | $3.84B | $2.47B | $2.56B | $2.57B | |
| Market Cap | $77.37B | $83.92B | $109.91B | $122.07B | $112.07B | $78.80B | $76.39B | $67.60B | $57.62B | $37.92B | $36.43B | $33.69B | |
| Enterprise Value | $99.93B | $106.86B | $128.50B | $138.79B | $130.22B | $93.09B | $91.54B | $82.88B | $73.94B | $49.57B | $50.18B | $46.69B | |
| P/E | 13.9 | 14.4 | 18.7 | 21.1 | 18.6 | 17.9 | 16.4 | 18.5 | 15.7 | 15.6 | 14.9 | 14.0 | |
| P/S | 0.4 | 0.5 | 0.6 | 0.8 | 0.8 | 0.6 | 0.7 | 0.7 | 0.6 | 0.4 | 0.5 | 0.5 | |
| P/B | 1.8 | 2.0 | 2.8 | 3.4 | 3.1 | 2.4 | 2.4 | 2.4 | 2.2 | 1.5 | 1.6 | 1.4 | |
| P / Tangible Book | 17.8 | 88.9 | 29.6 | 79.0 | 89.5 | 37.5 | · | · | · | · | · | · | |
| P / Cash Flow | 18.0 | 14.4 | 13.6 | 14.5 | 13.4 | 7.4 | 12.6 | 17.7 | 13.8 | 11.8 | 8.9 | 10.0 | |
| P / FCF | 24.4 | 18.4 | 16.2 | 16.8 | 15.4 | 8.2 | 15.3 | 25.8 | 17.0 | 14.5 | 10.5 | 12.7 | |
| EV / EBITDA | 11.4 | 11.5 | 12.5 | 13.7 | 14.8 | 12.4 | 15.3 | 15.3 | 17.7 | 10.3 | 10.6 | 10.6 | |
| EV / FCF | 31.5 | 23.5 | 19.0 | 19.2 | 17.9 | 9.6 | 18.4 | 31.6 | 21.8 | 18.9 | 14.4 | 17.6 | |
| EV / Revenue | 0.5 | 0.6 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | |
| Dividend Yield | 2.0% | 1.8% | 1.3% | 1.0% | 0.99% | 1.2% | 1.1% | 1.1% | 1.2% | 1.8% | 1.8% | 1.4% | |
| Earnings Yield | 7.2% | 7.0% | 5.3% | 4.7% | 5.4% | 5.6% | 6.1% | 5.4% | 6.4% | 6.4% | 6.7% | 7.1% | |
| Payout Ratio | 27.0% | 25.2% | 23.3% | 20.4% | 18.1% | 20.9% | 17.0% | 20.7% | 18.3% | 27.7% | 25.7% | 18.7% | |
| Annual Payout | $1.53B | $1.51B | $1.40B | $1.23B | $1.10B | $954M | $818M | $776M | $705M | $684M | $657M | $481M |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B | $45.11B | $43.89B | $42.58B | $42.65B | $42.85B | $43.67B | $42.17B | $39.93B | $39.94B | |
| Cost of Revenue | $5.49B | $5.46B | $5.52B | $5.38B | $5.29B | $4.98B | $6.01B | $5.09B | $4.82B | $3.83B | $4.84B | $4.65B | $4.33B | $3.48B | $3.65B | $3.44B | |
| SG&A Expense | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B | $5.27B | $5.07B | $4.89B | $5.00B | $5.47B | $4.82B | $4.80B | $4.57B | $4.52B | |
| Operating Income | $1.76B | $2.09B | $309M | $1.29B | $2.42B | $3.17B | $673M | $1.41B | $2.77B | $3.02B | $1.28B | $1.76B | $2.63B | $2.83B | $1.26B | $2.25B | |
| Interest Expense | · | · | · | · | · | · | · | $300M | $280M | $265M | · | $259M | $261M | $251M | · | $213M | |
| Pretax Income | $1.94B | $2.30B | $215M | $1.41B | $2.29B | $2.80B | $606M | $1.37B | $2.99B | $2.94B | $1.00B | $1.65B | $2.44B | $2.62B | $1.04B | $2.13B | |
| Income Tax | $483M | $544M | $-331M | $219M | $548M | $613M | $193M | $365M | $685M | $690M | $170M | $354M | $585M | $615M | $168M | $529M | |
| Net Income | $1.46B | $1.76B | $547M | $1.19B | $1.74B | $2.18B | $418M | $1.02B | $2.30B | $2.25B | $856M | $1.29B | $1.85B | $1.99B | $865M | $1.60B | |
| EPS (Basic) | $6.74 | $8.03 | $2.58 | $5.32 | $7.74 | $9.64 | $1.87 | $4.38 | $9.91 | $9.65 | $3.70 | $5.48 | $7.83 | $8.37 | $3.66 | $6.69 | |
| EPS (Diluted) | $6.71 | $8.00 | $2.56 | $5.32 | $7.72 | $9.61 | $1.88 | $4.36 | $9.85 | $9.59 | $3.68 | $5.45 | $7.79 | $8.30 | $3.61 | $6.62 | |
| Shares (Basic) | 217,000,000 | 219,800,000 | · | 223,300,000 | 225,200,000 | 226,400,000 | · | 231,900,000 | 232,200,000 | 232,700,000 | · | 235,300,000 | 236,600,000 | 237,500,000 | · | 239,600,000 | |
| Shares (Diluted) | 217,900,000 | 220,400,000 | · | 223,700,000 | 225,800,000 | 227,200,000 | · | 233,100,000 | 233,400,000 | 234,200,000 | · | 236,500,000 | 237,800,000 | 239,700,000 | · | 242,200,000 | |
| EBITDA | $1.76B | $2.44B | · | $1.29B | $2.42B | $3.54B | · | $1.64B | $2.77B | $3.35B | · | $1.76B | $2.63B | $3.29B | · | $2.27B |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10.23B | $9.66B | $9.49B | $8.71B | $8.56B | $7.50B | $8.29B | $7.87B | $6.50B | $6.23B | · | $10.92B | $9.99B | $10.14B | · | $8.87B | |
| Other Current Assets | $6.28B | $7.17B | $5.34B | $5.21B | $5.41B | $5.29B | $4.70B | $5.95B | $6.46B | $6.39B | · | $5.36B | $4.94B | $4.94B | · | $5.50B | |
| Current Assets | $67.18B | $67.03B | $63.00B | $63.78B | $63.32B | $61.12B | $58.94B | $62.85B | $62.27B | $60.95B | · | $61.19B | $59.74B | $59.82B | · | $55.60B | |
| PP&E (Net) | $4.64B | $4.66B | $4.68B | $4.66B | $4.64B | $4.62B | $4.65B | $4.50B | $4.45B | $4.45B | · | $4.25B | $4.55B | $4.42B | · | $4.20B | |
| PP&E (Gross) | · | · | $8.73B | · | · | · | $8.33B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4.06B | · | · | · | $3.68B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $28.34B | $28.34B | $28.34B | $28.45B | $28.37B | $28.42B | $28.28B | $25.97B | $25.96B | $25.95B | $25.32B | $25.29B | $25.27B | $25.27B | $24.38B | $24.38B | |
| Intangibles | $10.98B | $11.09B | $11.20B | $11.33B | $11.49B | $11.94B | $12.09B | $10.32B | $10.45B | $10.71B | · | $10.49B | $10.70B | $10.91B | · | $10.54B | |
| Other Non-current Assets | $2.90B | $2.58B | $2.31B | $2.78B | $2.56B | $2.39B | $2.14B | $2.60B | $2.20B | $2.25B | · | $2.33B | $2.13B | $1.86B | · | $2.17B | |
| Total Assets | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Accounts Payable | $6.63B | $6.21B | $7.32B | $6.08B | $7.28B | $7.13B | $6.93B | $6.25B | $5.76B | $5.66B | · | $5.98B | $5.03B | $4.87B | · | $4.96B | |
| Short-term Debt | $0 | $724M | $150M | $180M | $360M | $250M | $365M | $360M | $225M | $1.57B | · | $0 | $265M | $265M | · | $265M | |
| Current Liabilities | $44.25B | $45.31B | $41.03B | $40.88B | $43.83B | $42.70B | $40.58B | $42.03B | $41.81B | $44.33B | · | $43.34B | $41.57B | $41.89B | · | $41.29B | |
| Capital Leases | · | · | $529M | · | · | · | $658M | · | · | · | · | $695M | $717M | $727M | · | $739M | |
| Deferred Tax | $2.21B | $1.79B | $2.11B | $2.31B | $2.01B | $2.12B | $2.15B | $2.09B | $2.04B | $2.20B | · | $1.78B | $1.85B | $2.03B | · | $1.82B | |
| Other Non-current Liabilities | $4.29B | $3.92B | $3.38B | $4.14B | $3.90B | $3.99B | $3.33B | $3.59B | $1.99B | $1.91B | · | $1.97B | $1.78B | $1.65B | · | $1.79B | |
| Total Liabilities | $81.42B | $81.78B | $77.47B | $78.67B | $78.09B | $77.10B | $75.46B | $72.65B | $70.69B | $71.18B | · | $71.94B | $70.86B | $71.58B | · | $66.98B | |
| Long-term Debt | $31.04B | $31.12B | $31.90B | $31.92B | $29.83B | $29.75B | $30.87B | $26.79B | $27.46B | $24.88B | · | $24.84B | $24.86B | $25.20B | · | $23.51B | |
| Total Debt | $31.04B | $31.84B | · | $32.10B | $30.19B | $30.00B | · | $27.15B | $27.69B | $26.45B | · | $24.84B | $25.12B | $25.47B | · | $23.77B | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $2M | $2M | $2M | · | $2M | |
| Paid-in Capital | $8.92B | $8.85B | $8.94B | $8.91B | $8.93B | $8.87B | $8.91B | $9.11B | $9.00B | $8.88B | · | $8.83B | $8.76B | $8.70B | · | $9.17B | |
| Retained Earnings | $36.67B | $35.80B | $35.39B | $35.59B | $35.55B | $34.55B | $33.55B | $35.16B | $34.58B | $33.09B | · | $32.10B | $31.61B | $30.71B | · | $29.60B | |
| AOCI | $-711M | $-741M | $-451M | $-543M | $-760M | $-911M | $-1.15B | $-489M | $-1.39B | $-1.36B | · | $-2.51B | $-2.17B | $-2.05B | · | $-2.78B | |
| Stockholders' Equity | $44.88B | $43.90B | $43.88B | $43.95B | $43.72B | $42.50B | $41.31B | $43.77B | $42.19B | $40.61B | · | $38.42B | $38.20B | $37.36B | · | $35.99B | |
| Liabilities + Equity | $126.44B | $125.83B | $121.49B | $122.75B | $121.94B | $119.72B | $116.89B | $116.53B | $112.99B | $111.89B | · | $110.48B | $109.17B | $109.04B | · | $103.03B | |
| Shares Outstanding | 216,841,146 | 217,368,494 | 220,723,898 | 222,036,187 | 224,835,508 | 225,641,361 | 227,479,695 | 231,929,643 | 231,902,075 | 232,544,717 | · | 234,906,987 | 235,861,650 | 237,114,190 | · | 238,974,624 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $366M | $354M | $406M | $387M | $380M | $373M | $831M | $231M | $0 | $331M | $1.06B | $220M | $0 | $462M | $473M | $451M | |
| Stock-based Comp | $75M | $55M | $30M | $84M | $81M | $81M | $-29M | $66M | $92M | $62M | $72M | $78M | $78M | $61M | $73M | $69M | |
| Deferred Tax | $151M | $-274M | $-322M | $269M | $-52M | $-174M | $-116M | $-224M | $-170M | $136M | $-241M | $32M | $-138M | $-255M | $68M | $-11M | |
| Amort. of Intangibles | $110M | $112M | $164M | $162M | $147M | $155M | $180M | $122M | $162M | $116M | $217M | $212M | $221M | $235M | $247M | $225M | |
| Other Non-cash | · | $2.43B | · | · | · | $-1.45B | · | · | · | $-797M | · | · | · | $4.21B | · | · | |
| Operating Cash Flow | $1.91B | $4.33B | $84M | $1.14B | $2.05B | $1.02B | $706M | $2.68B | $447M | $1.98B | $-2.97B | $2.61B | $1.95B | $6.47B | $-1.52B | $4.92B | |
| CapEx | $287M | $235M | $293M | $360M | $267M | $196M | $322M | $332M | $323M | $279M | $326M | $319M | $350M | $301M | $298M | $305M | |
| Investing Cash Flow | $159M | $-1.64B | $464M | $-1.22B | $-687M | $103M | $-1.64B | $-401M | $-818M | $-2.31B | $-1.03B | $-687M | $-672M | $-3.18B | $289M | $-1.25B | |
| Debt Issued | · | · | $-3M | $2.99B | · | · | $5.13B | $0 | $2.58B | $0 | $0 | $0 | $0 | $2.57B | $1.78B | $-14M | |
| Net Debt Issued | · | $-750M | · | · | · | $-1.25B | · | · | · | $0 | · | · | · | $666M | · | · | |
| Stock Repurchased | $234M | $1.12B | $471M | $876M | $378M | $880M | $1.81B | $60M | $463M | $566M | $928M | $480M | $646M | $622M | $568M | $579M | |
| Net Stock Activity | · | $-1.12B | · | · | · | $-880M | · | · | · | $-566M | · | · | · | $-622M | · | · | |
| Dividends Paid | $373M | $376M | $377M | $376M | $385M | $386M | $373M | $386M | $378M | $379M | $346M | $348M | $350M | $351M | $305M | $306M | |
| Financing Cash Flow | $-1.49B | $-2.52B | $236M | $243M | $-308M | $-1.91B | $1.41B | $-915M | $668M | $32M | $-394M | $-994M | $-1.43B | $-531M | $-258M | $-1.25B | |
| Net Change in Cash | $575M | $166M | $778M | $153M | $1.06B | $-788M | $468M | $1.37B | $292M | $-300M | $-4.39B | $928M | $-151M | $2.75B | $-1.49B | $2.42B | |
| Free Cash Flow | · | $4.10B | · | · | · | $821M | · | · | · | $1.70B | · | · | · | $6.17B | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $1.50B | · | · | · | $5.98B | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 3.5% | 4.2% | · | 2.5% | 4.9% | 6.5% | · | 3.1% | 6.3% | 7.1% | · | 4.1% | 6.0% | 6.7% | · | 5.7% | |
| Net Margin | 2.9% | 3.5% | · | 2.3% | 3.5% | 4.5% | · | 2.2% | 5.2% | 5.3% | · | 3.0% | 4.2% | 4.7% | · | 4.0% | |
| Pretax Margin | 3.8% | 4.6% | · | 2.8% | 4.6% | 5.7% | · | 3.0% | 6.8% | 6.9% | · | 3.9% | 5.6% | 6.2% | · | 5.4% | |
| EBITDA Margin | 3.5% | 4.9% | · | 2.5% | 4.9% | 7.2% | · | 3.6% | 6.3% | 7.9% | · | 4.1% | 6.0% | 7.8% | · | 5.7% | |
| ROA | 1.2% | 1.4% | · | 0.99% | 1.5% | 1.9% | · | 0.90% | 2.1% | 2.0% | · | 1.2% | 1.8% | 1.9% | · | 1.6% | |
| ROE | 3.3% | 4.1% | · | 2.7% | 4.1% | 5.2% | · | 2.5% | 5.7% | 5.8% | · | 3.5% | 5.0% | 5.4% | · | 4.5% | |
| ROIC | 1.7% | 2.1% | · | 1.4% | 2.5% | 3.4% | · | 1.5% | 3.0% | 3.4% | · | 2.2% | 3.2% | 3.5% | · | 2.9% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.6 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.3 | |
| Quick Ratio | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.3 | 0.2 | 0.2 | · | 0.2 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.7 | · | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | · | · | · | · | · | · | · | 4.7 | 9.9 | 11.4 | · | 6.8 | 10.1 | 11.3 | · | 10.7 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $206.99 | $201.97 | · | $197.95 | $194.46 | $188.37 | · | $188.74 | $181.93 | $174.62 | · | $163.57 | $161.98 | $157.54 | · | $150.61 | |
| Revenue / Share | $231.64 | $227.68 | · | $226.69 | $220.44 | $215.19 | · | $193.50 | $188.03 | $181.80 | · | $181.18 | $183.65 | $175.94 | · | $164.90 | |
| Cash Flow / Share | · | $19.66 | · | · | · | $4.48 | · | · | · | $8.45 | · | · | · | $26.99 | · | · | |
| Cash / Share | $47.19 | $44.43 | · | $39.24 | $38.07 | $33.24 | · | $33.92 | $28.02 | $26.77 | · | $46.48 | $42.36 | $42.77 | · | $37.13 | |
| Dividend / Share | $1.72 | $1.72 | · | $1.71 | $1.71 | $1.71 | · | $1.63 | $1.63 | $1.63 | · | $1.48 | $1.48 | $1.48 | · | $1.28 | |
| Dividend Paid / Share | $1.72 | $1.72 | $1.71 | $1.72 | $1.71 | $1.71 | $1.63 | $1.71 | $1.63 | $1.63 | $1.48 | $1.48 | $1.48 | $1.48 | $1.28 | $1.28 | |
| EPS (TTM) | $22.59 | $23.60 | · | $24.53 | $23.57 | $25.70 | · | $27.48 | $28.57 | $26.51 | · | $25.15 | $26.32 | $25.26 | · | $25.53 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $201.11B | $200.41B | · | $194.82B | $189.22B | $183.32B | · | $174.22B | $171.96B | $171.75B | · | $168.62B | $165.71B | $160.67B | · | $153.25B | |
| Net Income TTM | $4.96B | $5.24B | · | $5.53B | $5.36B | $5.92B | · | $6.42B | $6.69B | $6.24B | · | $6.00B | $6.31B | $6.09B | · | $6.22B | |
| Market Cap | $83.86B | $63.63B | · | $71.74B | $87.45B | $98.14B | · | $120.60B | $125.66B | $120.58B | · | $102.28B | $104.79B | $109.03B | · | $108.55B | |
| Enterprise Value | $104.67B | $85.82B | · | $95.13B | $109.08B | $120.65B | · | $139.89B | $146.85B | $140.81B | · | $116.21B | $119.92B | $124.35B | · | $123.45B | |
| P/E | 17.1 | 12.4 | · | 13.2 | 16.5 | 16.9 | · | 18.9 | 19.0 | 19.6 | · | 17.3 | 16.9 | 18.2 | · | 17.8 | |
| P/S | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.5 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | |
| P/B | 1.9 | 1.4 | · | 1.6 | 2.0 | 2.3 | · | 2.8 | 3.0 | 3.0 | · | 2.7 | 2.7 | 2.9 | · | 3.0 | |
| P / Tangible Book | 15.1 | 14.2 | · | 17.2 | 22.6 | 45.8 | · | 16.1 | 21.7 | 30.5 | · | 38.7 | 47.0 | 93.3 | · | 101.1 | |
| P / Cash Flow | · | 14.7 | · | · | · | 96.5 | · | · | · | 61.0 | · | · | · | 16.9 | · | · | |
| EV / Revenue | 0.5 | 0.4 | · | 0.5 | 0.6 | 0.7 | · | 0.8 | 0.9 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.8 | |
| Dividend Yield | 1.8% | 2.4% | · | 2.1% | 1.8% | 1.6% | · | 1.2% | 1.1% | 1.2% | · | 1.3% | 1.2% | 1.2% | · | 1.1% | |
| Earnings Yield | 5.8% | 8.1% | · | 7.6% | 6.1% | 5.9% | · | 5.3% | 5.3% | 5.1% | · | 5.8% | 5.9% | 5.5% | · | 5.6% | |
| Payout Ratio | 25.5% | 21.3% | · | 32.0% | 22.1% | 17.7% | · | 37.2% | 16.4% | 16.9% | · | 27.0% | 18.9% | 17.6% | · | 18.9% | |
| Annual Payout | $1.50B | $1.51B | · | $1.52B | $1.53B | $1.52B | · | $1.49B | $1.45B | $1.42B | · | $1.35B | $1.31B | $1.27B | · | $1.20B |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $199.12B | $177.01B | $171.34B | $156.59B | $138.64B |
| Marża Operacyjna % | 3.6% | 4.4% | 5.0% | 5.4% | 5.4% |
| Zysk netto | $5.66B | $5.98B | $5.99B | $5.89B | $6.16B |
| Rozwodniony EPS | $25.21 | $25.68 | $25.22 | $24.28 | $24.95 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dług / Kapitał Własny | 0.7 | 0.8 | 0.6 | 0.7 | 0.6 |
| Wskaźnik bieżący | 1.5 | 1.5 | 1.4 | 1.4 | 1.5 |
| Wskaźnik Szybkości | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $3.17B | $4.55B | $6.76B | $7.25B | $7.28B |
Właściciele instytucjonalni (13F) 1 756 emitentów · $81.9B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 264 (+89 vs poprzedni kw.) | 94 (-110 vs poprzedni kw.) | 609 (+128 vs poprzedni kw.) | 550 (-104 vs poprzedni kw.) | +6.8M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $8 069 492 034 | 23 019 518 | 9,86% | Akcje |
| BlackRock, Inc. | $7 344 424 106 | 18 991 090 | 8,97% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $5 436 729 233 | 14 058 204 | 6,64% | Akcje |
| STATE STREET CORP | $4 032 282 885 | 10 426 610 | 4,93% | Akcje |
| WELLINGTON MANAGEMENT GROUP LLP | $3 563 141 883 | 9 213 513 | 4,35% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2 403 277 896 | 6 214 356 | 2,94% | Akcje |
| Sanders Capital, LLC | $2 252 711 532 | 5 825 024 | 2,75% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $1 990 239 599 | 5 166 124 | 2,43% | Akcje |
| HARRIS ASSOCIATES L P | $1 904 455 957 | 4 924 511 | 2,33% | Akcje |
| Artisan Partners Limited Partnership | $1 771 695 984 | 4 581 222 | 2,16% | Akcje |
| Invesco Ltd. | $1 637 504 097 | 4 234 231 | 2,00% | Akcje |
| First Eagle Investment Management, LLC | $1 619 701 186 | 4 188 196 | 1,98% | Akcje |
| NORGES BANK | $1 531 008 381 | 3 958 856 | 1,87% | Akcje |
| Bank of New York Mellon Corp | $1 246 348 719 | 3 222 787 | 1,52% | Akcje |
| FMR LLC | $1 211 103 818 | 3 131 652 | 1,48% | Akcje |
| MORGAN STANLEY | $1 007 728 234 | 2 605 764 | 1,23% | Akcje |
| NORTHERN TRUST CORP | $817 928 536 | 2 114 986 | 1,00% | Akcje |
| CITIGROUP INC | $810 919 703 | 2 096 863 | 0,99% | Akcje |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $779 725 026 | 2 016 200 | 0,95% | Akcje |
| GOLDMAN SACHS GROUP INC | $775 630 749 | 2 005 613 | 0,95% | Akcje |
| Nuveen, LLC | $769 539 548 | 1 989 863 | 0,94% | Akcje |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $749 415 810 | 1 935 880 | 0,92% | Akcje |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $737 324 542 | 2 518 615 | 0,90% | Akcje |
| BANK OF AMERICA CORP /DE/ | $698 537 689 | 1 806 267 | 0,85% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $697 546 062 | 1 803 703 | 0,85% | Akcje |
| Legal & General Group Plc | $688 469 125 | 1 780 232 | 0,84% | Akcje |
| Grantham, Mayo, Van Otterloo & Co. LLC | $654 221 093 | 1 691 671 | 0,80% | Akcje |
| Amundi | $635 991 799 | 1 644 537 | 0,78% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $601 132 524 | 1 554 359 | 0,73% | Akcje |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $591 084 393 | 1 528 416 | 0,72% | Akcje |
| EAGLE CAPITAL MANAGEMENT LLC | $576 772 638 | 1 491 409 | 0,70% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $511 706 827 | 1 323 163 | 0,63% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $461 498 831 | 1 193 336 | 0,56% | Akcje |
| BAILLIE GIFFORD & CO | $418 920 245 | 1 083 237 | 0,51% | Akcje |
| JPMORGAN CHASE & CO | $386 949 330 | 997 214 | 0,47% | Akcje |
| Ruane, Cunniff & Goldfarb L.P. | $378 839 935 | 979 598 | 0,46% | Akcje |
| Brave Warrior Advisors, LLC | $377 790 736 | 976 885 | 0,46% | Akcje |
| Newport Trust Company, LLC | $369 294 278 | 954 915 | 0,45% | Akcje |
| DEUTSCHE BANK AG\ | $364 707 273 | 943 054 | 0,45% | Akcje |
| FRANKLIN RESOURCES INC | $360 834 432 | 933 040 | 0,44% | Akcje |
| 1832 Asset Management L.P. | $355 109 795 | 918 237 | 0,43% | Akcje |
| CITADEL ADVISORS LLC | $350 526 658 | 906 386 | 0,43% | Akcje |
| Capital International Investors | $290 732 899 | 751 772 | 0,36% | Akcje |
| UBS Group AG | $286 115 618 | 739 833 | 0,35% | Akcje |
| ACR Alpine Capital Research, LLC | $285 376 389 | 737 922 | 0,35% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $281 369 666 | 727 561 | 0,34% | Akcje |
| ROYAL BANK OF CANADA | $268 753 000 | 694 935 | 0,33% | Akcje |
| High Ground Investment Management LLP | $262 939 273 | 679 904 | 0,32% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $261 530 030 | 676 260 | 0,32% | Akcje |
| Qube Research & Technologies Ltd | $247 577 198 | 640 181 | 0,30% | Akcje |
Insiderzy spółki 95 insiderów · 57 dyrektorzy generalni · 37 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Gail Boudreaux | President and CEO | 17 lipca 2026 P | 171 976 | 2 | 0 | $1 002 230 |
| Brian T Griffin | EVP & CEO, IngenioRx | 3 maja 2018 M | 15 863 | 0 | 0 | $0 |
| Angela F Braly | Chair, President & CEO | 1 marca 2012 A | 476 503 | 0 | 0 | $0 |
| Brian A Sassi | President & CEO Cons, EVP | 7 czerwca 2011 S | 60 825 | 0 | 0 | $0 |
| Dijuana K Lewis | Pres & CEO CHS and EVP | 20 maja 2010 M | 44 107 | 0 | 0 | $0 |
| Mark L Boxer | Pres & CEO of OT&GS and EVP | 4 kwietnia 2008 F | 42 143 | 0 | 0 | $0 |
| Joan E Herman | President & CEO Cons and EVP | 7 grudnia 2007 S | 30 369 | 0 | 0 | $0 |
| Mark Kaye | EVP & CFO | 2 marca 2026 A | 32 037 | 0 | 0 | $0 |
| John E Gallina | EVP & Chief Financial Officer | 1 marca 2023 A | 63 725 | 0 | 0 | $0 |
| Wayne S Deveydt | EVP & Chief Financial Officer | 3 marca 2016 F | 57 957 | 0 | 0 | $0 |
| David C Colby | Vice Chairman, CFO & EVP | 4 kwietnia 2007 F | 343 071 | 0 | 0 | $0 |
| Thomas R Byrd | President, Anthem Specialty | 26 listopada 2004 A | 26 580 | 0 | 0 | $0 |
| Michael D Houk | President, National Accounts | 4 listopada 2004 M | 18 843 | 0 | 0 | $0 |
| John M Murphy | President, Specialty Business | 17 maja 2004 A | 20 806 | 0 | 0 | $0 |
| Caroline S Matthews | Chief Operating Officer | 1 grudnia 2004 A | 40 471 | 0 | 0 | $0 |
| Erin M Wessling | EVP & Chief Legal Officer | 3 września 2026 F | 7 230 | 0 | 0 | $0 |
| Ryan R Craig | EVP & Chief HR Officer | 2 września 2026 F | 6 530 | 0 | 0 | $0 |
| Ronald W Penczek | CAO & Controller | 12 czerwca 2026 S | 3 740 | 0 | 2 | $-765 958 |
| Charles Morgan Kendrick JR | EVP & President, Commercial | 6 marca 2026 S | 11 791 | 0 | 1 | $-910 604 |
| Peter D Haytaian | EVP & Pres Carelon & CarelonRx | 3 marca 2026 F | 27 222 | 0 | 0 | $0 |
| Felicia F Norwood | EVP &Chief Health Benefits Ofr | 2 marca 2026 A | 38 838 | 0 | 0 | $0 |
| Ratnakar Lavu | EVP & Chief Digital Info Ofr | 2 marca 2026 A | 16 149 | 0 | 0 | $0 |
| Blair Williams Todt | EVP, CLO & CAO | 3 stycznia 2025 F | 15 631 | 0 | 0 | $0 |
| Gloria M Mccarthy | EVP & Chief Administrative Off | 24 marca 2023 S | 51 435 | 0 | 0 | $0 |
| Leah Stark | EVP & CHRO | 30 grudnia 2021 F | 12 403 | 0 | 0 | $0 |
| Jeffrey D. Alter | EVP, IngenioRx & Anthem Health | 1 października 2021 F | 5 107 | 0 | 0 | $0 |
| Patel Prakash R | EVP & President, DBG | 4 września 2021 F | 17 230 | 0 | 0 | $0 |
| Thomas C Zielinski | EVP & General Counsel | 3 listopada 2020 M | 17 910 | 0 | 0 | $0 |
| Craig E Samitt | EVP & President, DBG | 26 lipca 2018 M | 17 274 | 0 | 0 | $0 |
| Joseph Swedish | Executive Chairman | 5 marca 2018 S | 61 419 | 0 | 0 | $0 |
| Jacquelyn H Wolf | EVP & Chief HR Officer | 1 marca 2018 A | 3 105 | 0 | 0 | $0 |
| Jose D. Tomas | EVP & Chief HR Officer | 3 marca 2017 F | 23 927 | 0 | 0 | $0 |
| Samuel R Nussbaum MD | EVP & Chief Medical Officer | 19 maja 2015 M | 110 973 | 0 | 0 | $0 |
| Martin B Silverstein | EVP & Chief Strategy Officer | 1 maja 2015 F | 23 249 | 0 | 0 | $0 |
| Kenneth R Goulet | EVP, Commercial & Specialty | 2 marca 2015 A | 84 281 | 0 | 0 | $0 |
| Richard C Zoretic | EVP, Gov Business Division | 3 marca 2014 A | 53 572 | 0 | 0 | $0 |
| John Cannon | EVP, GC & Chief PAO | 13 grudnia 2013 S | 99 331 | 0 | 0 | $0 |
| Randal L Brown | EVP & Chief HR Officer | 4 września 2013 M | 30 332 | 0 | 0 | $0 |
| Lori A Beer | EVP, Specialty Businesses & IT | 30 maja 2013 M | 113 955 | 0 | 0 | $0 |
| Harlan A Levine | EVP, CHS | 31 sierpnia 2012 S | 25 244 | 0 | 0 | $0 |
| Venkata R Madabhushi | EVP Sr Bus & Chf Transfrmn Off | 2 kwietnia 2012 A | 45 237 | 0 | 0 | $0 |
| Miller Martin | SVP & Chief Accounting Officer | 1 marca 2011 A | 29 329 | 0 | 0 | $0 |
| Fluegel M Bradley | EVP, Chief Strategy Officer | 5 listopada 2010 M | 52 634 | 0 | 0 | $0 |
| Cynthia S Miller | EVP & Chief Actuary | 1 marca 2010 A | 60 757 | 0 | 0 | $0 |
| Randall J Lewis | EVP & Chief Compliance Officer | 7 sierpnia 2009 M | 13 658 | 0 | 0 | $0 |
| Jamie S Miller | SVP & Chief Accounting Officer | 3 marca 2008 A | 25 710 | 0 | 0 | $0 |
| Alice F Rosenblatt | EVP and Chief Actuary | 22 stycznia 2008 S | 39 265 | 0 | 0 | $0 |
| John S Watts JR | EVP | 7 grudnia 2007 S | 108 311 | 0 | 0 | $0 |
| Marjorie W Dorr | EVP | 22 maja 2007 M | 38 951 | 0 | 0 | $0 |
| Michael A Stocker | EVP | 23 października 2006 M | 42 186 | 0 | 0 | $0 |
| Keith R Faller | EVP | 12 września 2006 M | 83 290 | 0 | 0 | $0 |
| David S Helwig | EVP | 18 sierpnia 2006 M | 55 055 | 0 | 0 | $0 |
| Thomas G Snead JR | EVP | 31 stycznia 2006 M | 0 | 0 | 0 | $0 |
| Ronald J Ponder | EVP | 18 listopada 2005 M | 55 313 | 0 | 0 | $0 |
| David R Frick | EVP | 12 maja 2005 S | 58 241 | 0 | 0 | $0 |
| Michael L Smith | EVP | 18 lutego 2005 S | 98 810 | 0 | 0 | $0 |
| Jane E Niederberger | Senior Vice President and Chie | 17 maja 2004 A | 28 648 | 0 | 0 | $0 |
| Ramiro G Peru | Dyrektor | 17 lipca 2026 P | 10 908 | 1 | 0 | $366 050 |
| Robert L Dixon JR | Dyrektor | 11 czerwca 2026 S | 10 734 | 0 | 1 | $-60 667 |
| Bahija Jallal | Dyrektor | 13 maja 2026 A | 5 351 | 0 | 0 | $0 |
| Antonio F Neri | Dyrektor | 13 maja 2026 A | 5 488 | 0 | 0 | $0 |
| Susan D. Devore | Dyrektor | 13 maja 2026 A | 4 065 | 0 | 0 | $0 |
| Amy Schulman | Dyrektor | 13 maja 2026 A | 781 | 0 | 1 | $-7 475 |
| Ryan M. Schneider | Dyrektor | 13 maja 2026 A | 7 163 | 0 | 0 | $0 |
| Deanna D Strable-Soethout | Dyrektor | 13 maja 2026 A | 2 209 | 0 | 0 | $0 |
| Steven H Collis | Dyrektor | 13 maja 2026 A | 4 202 | 1 | 0 | $869 520 |
| Lewis Hay III | Dyrektor | 13 maja 2026 A | 12 070 | 0 | 0 | $0 |
| Kerry R Clark | Dyrektor | 14 maja 2025 A | 9 640 | 0 | 0 | $0 |
| Elizebeth E Tallett | Dyrektor | 15 maja 2024 A | 10 291 | 0 | 0 | $0 |
| Julie A Hill | Dyrektor | 20 maja 2021 S | 31 213 | 0 | 0 | $0 |
| George A Schaefer JR | Dyrektor | 16 maja 2018 A | 38 864 | 0 | 0 | $0 |
| William J Ryan | Dyrektor | 28 lipca 2016 S | 27 149 | 0 | 0 | $0 |
| John H Short | Dyrektor | 14 maja 2014 A | 2 981 | 0 | 0 | $0 |
| Warren Y Jobe | Dyrektor | 13 marca 2014 G | 26 525 | 0 | 0 | $0 |
| Lenox D Baker JR MD | Dyrektor | 8 marca 2013 M | 71 155 | 0 | 0 | $0 |
| Susan B Bayh | Dyrektor | 21 maja 2012 S | 0 | 0 | 0 | $0 |
| Sheila P Burke | Dyrektor | 16 maja 2012 A | 16 200 | 0 | 0 | $0 |
| Jackie M Ward | Dyrektor | 16 maja 2012 A | 23 806 | 0 | 0 | $0 |
| William H T Bush | Dyrektor | 17 maja 2011 M | 28 383 | 0 | 0 | $0 |
| William G Mays | Dyrektor | 17 maja 2011 A | 19 878 | 0 | 0 | $0 |
| Donald W Riegle JR | Dyrektor | 16 maja 2011 M | 3 894 | 0 | 0 | $0 |
| Jane G Pisano | Dyrektor | 10 maja 2010 M | 3 692 | 0 | 0 | $0 |
| Victor S Liss | Dyrektor | 10 maja 2010 M | 4 658 | 0 | 0 | $0 |
| Larry C Glasscock | Dyrektor | 25 lutego 2010 M | 3 352 | 0 | 0 | $0 |
| John Zuccotti | Dyrektor | 20 maja 2009 A | · | 0 | 0 | $0 |
| Ben L Lytle | Dyrektor | 10 maja 2005 A | 2 128 | 0 | 0 | $0 |
| Leonard D Schaeffer | Dyrektor | 10 maja 2005 A | 1 041 024 | 0 | 0 | $0 |
| Allan B Hubbard | Dyrektor | 14 lutego 2005 M | 0 | 0 | 0 | $0 |
| John Sherman JR | Dyrektor | 1 grudnia 2004 M | 4 164 | 0 | 0 | $0 |
| James W Mcdowell JR | Dyrektor | 1 października 2004 A | 1 271 | 0 | 0 | $0 |
| Dennis J Sullivan JR | Dyrektor | 26 lipca 2004 M | 2 837 | 0 | 0 | $0 |
| Leeba Lessin | · | 1 marca 2013 A | 15 451 | 0 | 0 | $0 |
| Rebecca A Kapustay | · | 1 kwietnia 2005 M | 34 557 | 0 | 0 | $0 |
| SANDERS ELIZABETH A | · | 3 marca 2005 S | 35 604 | 0 | 0 | $0 |
| William B Hart | · | 1 października 2004 A | 439 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 165 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| IHF · iShares Trust | 7,53% | 237 106 SH | 11 września 2026 | Dziennie |
| CVGD · Elevation Series Trust | 3,56% | 13 113 NS | 31 lipca 2026 | N-PORT |
| FDIV · EA Series Trust | 1,95% | 3 050 NS | 31 lipca 2026 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 1,65% | 80 785 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,64% | 45 819 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,61% | 36 334 SH | 5 października 2026 | Dziennie |
| RPV · Invesco Exchange-Traded Fund Trust | 1,56% | 67 254 SH | 5 października 2026 | Dziennie |
| PWV · Invesco Exchange-Traded Fund Trust | 1,47% | 69 546 SH | 5 października 2026 | Dziennie |
| IYH · iShares Trust | 1,46% | 127 077 SH | 11 września 2026 | Dziennie |
| SRHQ · Elevation Series Trust | 1,41% | 7 981 NS | 31 lipca 2026 | N-PORT |
| IMCV · iShares Trust | 1,22% | 34 046 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 1,22% | 645 908 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 1,19% | 104 494 NS | 31 lipca 2026 | N-PORT |
| VMAX · Lattice Strategies Trust | 1,18% | 1 543 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 1,15% | 114 143 SH | 11 września 2026 | Dziennie |
| REVS · Columbia ETF Trust I | 1,12% | 9 954 NS | 31 lipca 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 1,00% | 252 869 SH | 5 października 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,94% | 4 273 NS | 31 lipca 2026 | N-PORT |
| NUDV · Nushares ETF Trust | 0,92% | 1 235 NS | 31 lipca 2026 | N-PORT |
| SYLD · Cambria ETF Trust | 0,92% | 24 249 NS | 31 lipca 2026 | N-PORT |
| ESMV · iShares Trust | 0,91% | 170 SH | 11 września 2026 | Dziennie |
| EQIN · Columbia ETF Trust I | 0,86% | 6 959 NS | 31 lipca 2026 | N-PORT |
| ROUS · Lattice Strategies Trust | 0,74% | 13 856 NS | 31 lipca 2026 | N-PORT |
| VFVA · VANGUARD WELLINGTON FUND | 0,73% | 15 896 SH | 19 sierpnia 2026 | Dziennie |
| RECS · Columbia ETF Trust I | 0,73% | 112 966 NS | 31 lipca 2026 | N-PORT |
| VLUE · iShares Trust | 0,71% | 163 004 SH | 11 września 2026 | Dziennie |
| NULC · Nushares ETF Trust | 0,69% | 1 301 NS | 31 lipca 2026 | N-PORT |
| FBCV · FIDELITY COVINGTON TRUST | 0,68% | 3 202 NS | 31 lipca 2026 | N-PORT |
| FEUS · FlexShares Trust | 0,61% | 1 815 NS | 31 lipca 2026 | N-PORT |
| IMCB · iShares Trust | 0,61% | 24 486 SH | 11 września 2026 | Dziennie |
| FDLO · FIDELITY COVINGTON TRUST | 0,60% | 22 637 NS | 31 lipca 2026 | N-PORT |
| DIVB · iShares Trust | 0,54% | 26 159 SH | 11 września 2026 | Dziennie |
| IDRV · iShares Trust | 0,53% | 143 110 SH | 11 września 2026 | Dziennie |
| RDVI · First Trust Exchange-Traded Fund IV | 0,52% | 50 065 NS | 31 lipca 2026 | N-PORT |
| XOEF · iShares Trust | 0,51% | 273 SH | 11 września 2026 | Dziennie |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,50% | 12 654 SH | 5 października 2026 | Dziennie |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,49% | 18 161 NS | 31 lipca 2026 | N-PORT |
| BSCU · Invesco Exchange-Traded Self-Indexe… | 0,47% | 13 779 000 | 5 października 2026 | Dziennie |
| BSCS · Invesco Exchange-Traded Self-Indexe… | 0,45% | 16 107 990 | 5 października 2026 | Dziennie |
| SUSA · iShares Trust | 0,45% | 43 466 SH | 11 września 2026 | Dziennie |
| ACWV · iShares, Inc. | 0,44% | 35 074 SH | 11 września 2026 | Dziennie |
| QUVU · Hartford Funds Exchange-Traded Trust | 0,42% | 2 019 NS | 31 lipca 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,42% | 106 885 SH | 5 października 2026 | Dziennie |
| PALC · Pacer Funds Trust | 0,42% | 2 320 NS | 31 lipca 2026 | N-PORT |
| EVUS · iShares Trust | 0,40% | 3 683 SH | 11 września 2026 | Dziennie |
| MGV · VANGUARD WORLD FUND | 0,39% | 133 635 SH | 19 sierpnia 2026 | Dziennie |
| DFUV · Dimensional ETF Trust | 0,38% | 154 644 NS | 31 lipca 2026 | N-PORT |
| PFIG · Invesco Exchange-Traded Fund Trust … | 0,38% | 515 000 | 2 października 2026 | Dziennie |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,37% | 8 210 NS | 31 lipca 2026 | N-PORT |
| BSCR · Invesco Exchange-Traded Self-Indexe… | 0,37% | 16 621 000 | 5 października 2026 | Dziennie |
| USXF · iShares Trust | 0,36% | 12 883 SH | 11 września 2026 | Dziennie |
| DFLV · Dimensional ETF Trust | 0,36% | 65 144 NS | 31 lipca 2026 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 0,36% | 1 200 113 SH | 19 sierpnia 2026 | Dziennie |
| FHEQ · Fidelity Greenwood Street Trust | 0,35% | 8 603 NS | 31 lipca 2026 | N-PORT |
| VYM · VANGUARD WHITEHALL FUNDS | 0,34% | 847 792 SH | 19 sierpnia 2026 | Dziennie |
| CVY · Invesco Exchange-Traded Fund Trust | 0,34% | 1 030 SH | 5 października 2026 | Dziennie |
| IWX · iShares Trust | 0,34% | 31 304 SH | 11 września 2026 | Dziennie |
| USMV · iShares Trust | 0,32% | 181 462 SH | 11 września 2026 | Dziennie |
| BSCT · Invesco Exchange-Traded Self-Indexe… | 0,31% | 9 525 000 | 5 października 2026 | Dziennie |
| DGRO · iShares Trust | 0,31% | 320 084 SH | 11 września 2026 | Dziennie |
| VTV · VANGUARD INDEX FUNDS | 0,31% | 2 021 174 SH | 19 sierpnia 2026 | Dziennie |
| PFM · Invesco Exchange-Traded Fund Trust | 0,31% | 6 186 SH | 5 października 2026 | Dziennie |
| IVE · iShares Trust | 0,30% | 360 968 SH | 11 września 2026 | Dziennie |
| ACIO · ETF Series Solutions | 0,29% | 18 049 NS | 31 lipca 2026 | N-PORT |
| IUSV · iShares Trust | 0,29% | 189 556 SH | 11 września 2026 | Dziennie |
| ADME · ETF Series Solutions | 0,28% | 2 222 NS | 31 lipca 2026 | N-PORT |
| HDUS · Lattice Strategies Trust | 0,28% | 1 531 NS | 31 lipca 2026 | N-PORT |
| ESG · FlexShares Trust | 0,28% | 990 NS | 31 lipca 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,28% | 48 913 SH | 19 sierpnia 2026 | Dziennie |
| SUSL · iShares Trust | 0,26% | 7 654 SH | 11 września 2026 | Dziennie |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,26% | 10 930 NS | 31 lipca 2026 | N-PORT |
| DSI · iShares Trust | 0,26% | 33 146 SH | 11 września 2026 | Dziennie |
| ILCV · iShares Trust | 0,25% | 8 135 SH | 11 września 2026 | Dziennie |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,24% | 1 096 NS | 31 lipca 2026 | N-PORT |
| IWD · iShares Trust | 0,24% | 482 434 SH | 11 września 2026 | Dziennie |
| IQSU · New York Life Investments ETF Trust | 0,24% | 2 111 NS | 31 lipca 2026 | N-PORT |
| FBUF · Fidelity Greenwood Street Trust | 0,24% | 152 NS | 31 lipca 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 2 806 NS | 31 lipca 2026 | N-PORT |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,23% | 128 096 SH | 19 sierpnia 2026 | Dziennie |
| ESGG · FlexShares Trust | 0,21% | 627 NS | 31 lipca 2026 | N-PORT |
| EUSA · iShares, Inc. | 0,21% | 9 792 SH | 11 września 2026 | Dziennie |
| FYEE · Fidelity Greenwood Street Trust | 0,21% | 1 194 NS | 31 lipca 2026 | N-PORT |
| GLBL · Pacer Funds Trust | 0,20% | 6 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 490 516 SH | 5 października 2026 | Dziennie |
| ESGU · iShares Trust | 0,19% | 83 443 SH | 11 września 2026 | Dziennie |
| SIZE · iShares Trust | 0,19% | 1 938 SH | 11 września 2026 | Dziennie |
| USCL · iShares Trust | 0,17% | 11 477 SH | 11 września 2026 | Dziennie |
| TOPC · iShares Trust | 0,17% | 133 SH | 11 września 2026 | Dziennie |
| DFSU · Dimensional ETF Trust | 0,16% | 9 705 NS | 31 lipca 2026 | N-PORT |
| IWL · iShares Trust | 0,16% | 8 413 SH | 11 września 2026 | Dziennie |
| XVV · iShares Trust | 0,15% | 2 493 SH | 11 września 2026 | Dziennie |
| MGC · VANGUARD WORLD FUND | 0,15% | 42 364 SH | 19 sierpnia 2026 | Dziennie |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,15% | 6 380 SH | 5 października 2026 | Dziennie |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,14% | 17 682 SH | 5 października 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,14% | 47 980 SH | 19 sierpnia 2026 | Dziennie |
| IVV · iShares Trust | 0,14% | 2 737 349 SH | 11 września 2026 | Dziennie |
| ACVF · ETF Opportunities Trust | 0,14% | 548 NS | 31 lipca 2026 | N-PORT |
| ILCB · iShares Trust | 0,13% | 4 087 SH | 11 września 2026 | Dziennie |
| BKLC · BNY Mellon ETF Trust | 0,13% | 18 995 NS | 31 lipca 2026 | N-PORT |
| VOO · VANGUARD INDEX FUNDS | 0,13% | 5 589 584 SH | 19 sierpnia 2026 | Dziennie |
| VV · VANGUARD INDEX FUNDS | 0,13% | 248 024 SH | 19 sierpnia 2026 | Dziennie |
| IWB · iShares Trust | 0,13% | 150 486 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,13% | 9 294 SH | 11 września 2026 | Dziennie |
| PBP · Invesco Exchange-Traded Fund Trust | 0,13% | 1 291 SH | 5 października 2026 | Dziennie |
| PTLC · Pacer Funds Trust | 0,13% | 11 007 NS | 31 lipca 2026 | N-PORT |
| PBUS · Invesco Exchange-Traded Fund Trust … | 0,13% | 35 097 SH | 5 października 2026 | Dziennie |
| IWV · iShares Trust | 0,12% | 59 652 SH | 11 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,12% | 282 740 SH | 11 września 2026 | Dziennie |
| BBUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,12% | 28 858 NS | 31 lipca 2026 | N-PORT |
| VOTE · TCW ETF Trust | 0,12% | 3 538 NS | 31 lipca 2026 | N-PORT |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,12% | 35 020 SH | 19 sierpnia 2026 | Dziennie |
| TOV · EA Series Trust | 0,12% | 873 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,12% | 65 434 NS | 31 lipca 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,12% | 1 719 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,12% | 820 NS | 31 lipca 2026 | N-PORT |
| VOXP · Advisors Series Trust | 0,12% | 18 NS | 31 lipca 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,12% | 5 228 NS | 31 lipca 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,11% | 6 834 097 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,11% | 17 880 SH | 19 sierpnia 2026 | Dziennie |
| TOK · iShares Trust | 0,11% | 620 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,11% | 171 SH | 5 października 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,11% | 134 751 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,10% | 6 004 NS | 31 lipca 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,10% | 1 508 NS | 31 lipca 2026 | N-PORT |
| URTH · iShares, Inc. | 0,10% | 19 735 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,10% | 8 835 NS | 31 lipca 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,10% | 31 680 NS | 31 lipca 2026 | N-PORT |
| SPXL · Direxion Shares ETF Trust | 0,09% | 16 978 NS | 31 lipca 2026 | N-PORT |
| GLOF · iShares Trust | 0,09% | 455 SH | 11 września 2026 | Dziennie |
| LGDX · Tidal Trust III | 0,09% | 342 NS | 31 lipca 2026 | N-PORT |
| ACWI · iShares Trust | 0,09% | 69 481 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 1 815 SH | 5 października 2026 | Dziennie |
| CRBN · iShares Trust | 0,08% | 2 188 SH | 11 września 2026 | Dziennie |
| NEAR · iShares U.S. ETF Trust | 0,08% | 3 886 000 SH | 11 września 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,07% | 290 778 SH | 19 sierpnia 2026 | Dziennie |
| PICK · iShares, Inc. | 0,06% | 266 862 SH | 11 września 2026 | Dziennie |
| DFVX · Dimensional ETF Trust | 0,05% | 720 NS | 31 lipca 2026 | N-PORT |
| LRGF · iShares Trust | 0,03% | 2 746 SH | 11 września 2026 | Dziennie |
| VSS · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 571 538 SH | 19 sierpnia 2026 | Dziennie |
| SCZ · iShares Trust | 0,03% | 625 241 SH | 11 września 2026 | Dziennie |
| PEVC · Pacer Funds Trust | 0,02% | 1 NS | 31 lipca 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 13 133 SH | 11 września 2026 | Dziennie |
| IPAC · iShares Trust | 0,01% | 52 224 SH | 11 września 2026 | Dziennie |
| VPL · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 158 652 SH | 19 sierpnia 2026 | Dziennie |
| WSML · iShares Trust | 0,01% | 9 378 SH | 11 września 2026 | Dziennie |
| IEFA · iShares Trust | 0,00% | 1 291 652 SH | 11 września 2026 | Dziennie |
| IDEV · iShares Trust | 0,00% | 211 325 SH | 11 września 2026 | Dziennie |
| IXUS · iShares Trust | 0,00% | 168 378 SH | 11 września 2026 | Dziennie |
| VXUS · VANGUARD STAR FUNDS | 0,00% | 2 181 735 SH | 19 sierpnia 2026 | Dziennie |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,00% | 1 468 301 SH | 19 sierpnia 2026 | Dziennie |
| VSGX · VANGUARD WORLD FUND | 0,00% | 30 111 SH | 19 sierpnia 2026 | Dziennie |
| BIV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BLV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BSV · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| BND · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VUSB · VANGUARD BOND INDEX FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VSDB · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCSH · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCIT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VCLT · VANGUARD SCOTTSDALE FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VTC · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| BNDW · VANGUARD SCOTTSDALE FUNDS | · | · | 30 lipca 2026 | Dziennie |
| VCEB · VANGUARD WORLD FUND | · | · | 30 lipca 2026 | Dziennie |
ELV Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
12-miesięczny cel cenowy
21 analityków · 2026-10-01Średnia cel $451.38 +12,8%
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | · |
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | · |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | · |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | · |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| CLOV | · | -5.1 | 40.3% | -4.5% | -26.2% | · |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
| ALHC | $4.03B | · | 46.1% | -0.02% | -0.52% | · |
Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.